Zefylti will be available as 30 MU/0.5 mL and 48 MU/0.5 mL and is intended for the treatment of neutropenia and the mobilisation of peripheral progenitor cells
Dr. Reddy's had previously received the EU GMP certificate for its Rituximab drug substance
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
The GMP facility is equipped with state of art machinery for the needs of Global commercial requirements
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The company has already embarked upon significant expansion in Turkey
Subscribe To Our Newsletter & Stay Updated
